Quantcast

Latest Blood disorders Stories

2012-08-22 12:19:10

A University of Rochester Medical Center study challenges treatment guidelines for early stage follicular lymphoma, concluding that six different therapies can bring a remission, particularly if the patient is carefully examined and staged at diagnosis. The research underlines the fact that when cancer strikes, modern patients and their oncologists across the United States are taking many diverse treatment paths when there is scant data to support one method over another. This study...

2012-08-13 22:03:30

Discovery of the genetic basis of a high-risk subtype of leukemia shows some patients might benefit from existing targeted therapies, advancing the goal of curing all children with the most common childhood cancer Scientists have identified new genetic alterations underlying a high-risk subtype of the most common childhood cancer that could be effectively targeted with existing leukemia therapies. The study focused on a subtype of acute lymphoblastic leukemia (ALL) known as Philadelphia...

2012-08-13 15:51:54

Scientists at Albert Einstein College of Medicine of Yeshiva University have made a discovery involving mice and humans that could mean that people with acute myeloid leukemia (AML), a rare and usually fatal cancer, are a step closer to new treatment options. "We have discovered that a gene called HLX is expressed at abnormally high levels in leukemia stem cells in a mouse model of AML," said Ulrich Steidl, M.D., Ph.D., assistant professor of cell biology and of medicine at Einstein and...

Cancer Patient Saved With Pluristem PLX Cells
2012-08-09 09:30:16

Connie K. Ho for redOrbit.com — Your Universe Online Dressed in a white coat, a physician wrapped a piece of gauze around the arm of a female wearing a black shirt. The female was tense and anxious, sitting patiently as vials were attached to her arm. These actions could possibly decide the next step of her treatment. This is a typical scene at Pluristem Therapeutics, an Israeli-based company that focuses on placenta-based cell therapies. Pluristem Therapeutics developed this...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related